Medicskin Holdings Limited (MEDICSKIN) reported that every motion tabled at its Annual General Meeting (AGM) on 6 August 2026 was passed by poll with unanimous shareholder support.

Unanimous Voting Results • Each of the eight ordinary resolutions received 274.87 million votes in favour, representing 100.00% of votes cast, with no votes against. • Tricor Investor Services Limited acted as the independent scrutineer.

Capital Represented • The company had 396.74 million ordinary shares in issue on the AGM date, all entitled to vote. • Votes cast equated to 69.29% of total issued shares.

Key Resolutions Approved 1. Financial Statements: Adoption of the audited consolidated results for the year ended 31 March 2026, together with directors’ and auditor’s reports. 2. Board Composition: Re-election of Executive Directors Ms. Tsui Kan and Ms. Sin Chui Pik Christine, and Independent Non-Executive Director Mr. Lui Sze On; the board is authorised to set directors’ remuneration. 3. Auditor: Re-appointment of Grant Thornton Hong Kong Limited, with remuneration to be determined by the board. 4. Share Mandates: • Authority to issue new shares up to 20% of issued capital. • Authority to buy back shares up to 10% of issued capital. • Extension of the issue mandate by the number of shares repurchased.

Board Attendance Executive Directors Dr. Kong Kwok Leung, Ms. Tsui Kan, and Ms. Sin Chui Pik Christine, along with Independent Non-Executive Directors Mr. Chan Cheong Tat, Mr. Leung Siu Cheung, and Mr. Lui Sze On attended the AGM; Executive Director Ms. Kong Chung Wai was absent due to work commitments.

Regulatory Compliance No shareholders were required to abstain or voted against any resolution, and no treasury or pending-cancellation shares existed, confirming full compliance with GEM Listing Rules.